Friday, August 14, 2020 6:48:06 PM
Absolutely not a good thing. This is where I think we just struck gold. Aviptadil stops covid replication in the lungs. If every man, woman and child had an inhaler in this world of RLF-100, we might stop the spread since it’s main exit point is respiratory droplets in the lungs.
Disclaimer.
I am not a professional investment adviser. All things I post are in my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. My posts are made in the form of anecdotes.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
